Security key
816944102
Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (SNTI)
CUSIP: 816944102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 334
- Total 13F value
- $367
- Share change
- +334
- SEC-reported price per share
- $1.10
- Number of holders
- 1
- Value change
- +$367
- Number of buys
- 1
- Shares outstanding
- 47,159,139
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
SNTI full security history
Ownership snapshot
Full 13F holder table
Senti Biosciences Holdings, Inc. SEC filings
Senti Biosciences Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 816944102
Recent filing periods:
Ownership snapshot
Top reported holders of SNTI - Senti Biosciences Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Celadon Partners SPV 24
Disclosed value leader
Celadon Partners SPV 24
Comparable rows
15/15
Latest evidence
27 Apr 2026
13D/G
3/4/5
13F
Lead comparable stake: 55%
13D/G row: Celadon Partners SPV 24
Showing 1-6 of 15 holder rows.
Quick read
Celadon Partners SPV 24 leads the comparable SEC ownership view at 55%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Celadon Partners SPV 24's linked filing trail.
Comparable ownership
Top 5
Celadon Partners SPV 24
55%
BAYER HEALTHCARE LLC
18%
New Enterprise Associates 15, L.P.
12%
Nantahala Capital Management, LLC
8.1%
ARMISTICE CAPITAL, LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Celadon Partners SPV 24 |
13D/G
3/4/5
10%+ Owner
|
55%
|
$23,174,001
25,748,890 shares
|
+$11,013,811 | 27 Apr 2026 |
| BAYER HEALTHCARE LLC |
3/4/5
13D/G
10%+ Owner
|
18%
from 13D/G
|
$6,322,158
6,139,848 shares
mixed-class rows
|
— | 10 Mar 2025 |
| New Enterprise Associates 15, L.P. |
3/4/5
13D/G
10%+ Owner
|
12%
from 13D/G
|
$8,495,134
3,775,615 shares
|
— | 10 Mar 2025 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
8.1%
|
$7,037,400
2,220,000 shares
|
+$5,422,973 | 31 Mar 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$4,564,204
1,439,812 shares
|
+$2,865,052 | 31 Mar 2025 |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
1.9%
|
$1,592,925
502,500 shares
|
+$637,170 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
334
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
0
Q2 2026 holders
1
Holder diff
1
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend